Summers Value Partners Established a Position in UniQure N.V. (QURE) in Q3

4 days ago 7

Soumya Eswaran

Wed, November 19, 2025 astatine 7:16 AM CST 3 min read

Summers Value Partners, an concern absorption company, released its third-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. The Summers Value Fund LP returned a nett instrumentality of 20.4% nett successful Q3 2025, surpassing the 12.4% instrumentality of the Russell 2000 Index ETF (IWM) and the 12.5% instrumentality for the Russell 2000 Value Index ETF (IWN). Year-to-date, the money is up 4.9% nett compared to 10.3% and 8.9% returns for the indexes, respectively. In addition, you tin cheque the fund’s apical 5 holdings to find retired its champion picks for 2025.

In its third-quarter 2025 capitalist letter, Summers Value Partners highlighted stocks specified arsenic UniQure N.V. (NASDAQ:QURE). UniQure N.V. (NASDAQ:QURE) is simply a biotechnology institution that engages successful the improvement of treatments for patients suffering from uncommon and different devastating diseases. The one-month instrumentality of UniQure N.V. (NASDAQ:QURE) was -50.41%, and its shares gained 421.23% of their worth implicit the past 52 weeks. On November 18, 2025, UniQure N.V. (NASDAQ:QURE) banal closed astatine $29.71 per share, with a marketplace capitalization of $1.851 billion.

Summers Value Partners stated the pursuing regarding UniQure N.V. (NASDAQ:QURE) successful its 3rd 4th 2025 capitalist letter:

"The Fund held 12 agelong positions and nary shorts astatine quarter-end. We initiated a presumption successful UniQure N.V. (NASDAQ:QURE) pursuing encouraging Phase 3 results for its cistron therapy cause successful Huntington’s Disease, which showed a 75% simplification successful illness progression – a game-changing result successful a tract that has been devoid of objective progress. Given the aboriginal signifier of development, we person sized the presumption appropriately. "

Is uniQure N.V. (QURE) the Most Promising Growth Stock According to Wall Street Analysts?

UniQure N.V. (NASDAQ:QURE) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. According to our database, 36 hedge money portfolios held UniQure N.V. (NASDAQ:QURE) astatine the extremity of the 2nd quarter, up from 35 successful the erstwhile quarter. In the September quarter, UniQure N.V. (NASDAQ:QURE) reported $3.7 cardinal successful gross compared to $2.3 cardinal successful Q3 2024. While we admit the imaginable of UniQure N.V. (NASDAQ:QURE) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

In another article, we covered UniQure N.V. (NASDAQ:QURE) and shared the database of hottest tiny headdress stocks to buy. In addition, delight cheque retired our hedge money capitalist letters Q3 2025 page for much capitalist letters from hedge funds and different starring investors.